Cargando…
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Lipid Association. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353976/ https://www.ncbi.nlm.nih.gov/pubmed/34470719 http://dx.doi.org/10.1016/j.jacl.2021.08.002 |
_version_ | 1783736510071177216 |
---|---|
author | Dai, Wen Lund, Hayley Chen, Yiliang Zhang, Jue Osinski, Kristen Jones, Stephanie Zellner Kreuziger, Lisa Baumann López, José A. Benjamin, Ivor J. Silverstein, Roy L. Zheng, Ze |
author_facet | Dai, Wen Lund, Hayley Chen, Yiliang Zhang, Jue Osinski, Kristen Jones, Stephanie Zellner Kreuziger, Lisa Baumann López, José A. Benjamin, Ivor J. Silverstein, Roy L. Zheng, Ze |
author_sort | Dai, Wen |
collection | PubMed |
description | BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride level and mortality in hospitalized COVID-19 patients. METHODS: We conducted a retrospective study of 600 hospitalized patients with COVID-19 diagnosis (ICD10CM:U07.1) and/or SARS-CoV-2 positive testing results between March 1, 2020 and December 21, 2020 at a tertiary academic medical center in Milwaukee, Wisconsin. De-identified data, including demographics, medical history, and blood triglyceride levels were collected and analyzed. Of the 600 patients, 109 patients died. The triglyceride value on admission was considered the baseline and the peak was defined as the highest level reported during the entire period of hospitalization. Hypertriglyceridemia was defined as greater than 150 mg/dl. Logistic regression analyses were performed to evaluate the association between hypertriglyceridemia and mortality. RESULTS: There was no significant difference in baseline triglyceride levels between non-survivors (n = 109) and survivors (n = 491) [Median 127 vs. 113 mg/dl, p = 0.213]. However, the non-survivors had significantly higher peak triglyceride levels during hospitalization [Median 179 vs. 134 mg/dl, p < 0.001]. Importantly, hypertriglyceridemia independently associated with mortality [odds ratio=2.3 (95% CI: 1.4–3.7, p = 0.001)], after adjusting for age, gender, obesity, history of hypertension and diabetes, high CRP, high leukocyte count and glucocorticoid treatment in a multivariable logistic regression model. CONCLUSIONS: Hypertriglyceridemia during hospitalization is independently associated with 2.3 times higher mortality in COVID-19 patients. Prospective studies are needed to independently validate this retrospective analysis. |
format | Online Article Text |
id | pubmed-8353976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | National Lipid Association. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83539762021-08-10 Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 Dai, Wen Lund, Hayley Chen, Yiliang Zhang, Jue Osinski, Kristen Jones, Stephanie Zellner Kreuziger, Lisa Baumann López, José A. Benjamin, Ivor J. Silverstein, Roy L. Zheng, Ze J Clin Lipidol Article BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride level and mortality in hospitalized COVID-19 patients. METHODS: We conducted a retrospective study of 600 hospitalized patients with COVID-19 diagnosis (ICD10CM:U07.1) and/or SARS-CoV-2 positive testing results between March 1, 2020 and December 21, 2020 at a tertiary academic medical center in Milwaukee, Wisconsin. De-identified data, including demographics, medical history, and blood triglyceride levels were collected and analyzed. Of the 600 patients, 109 patients died. The triglyceride value on admission was considered the baseline and the peak was defined as the highest level reported during the entire period of hospitalization. Hypertriglyceridemia was defined as greater than 150 mg/dl. Logistic regression analyses were performed to evaluate the association between hypertriglyceridemia and mortality. RESULTS: There was no significant difference in baseline triglyceride levels between non-survivors (n = 109) and survivors (n = 491) [Median 127 vs. 113 mg/dl, p = 0.213]. However, the non-survivors had significantly higher peak triglyceride levels during hospitalization [Median 179 vs. 134 mg/dl, p < 0.001]. Importantly, hypertriglyceridemia independently associated with mortality [odds ratio=2.3 (95% CI: 1.4–3.7, p = 0.001)], after adjusting for age, gender, obesity, history of hypertension and diabetes, high CRP, high leukocyte count and glucocorticoid treatment in a multivariable logistic regression model. CONCLUSIONS: Hypertriglyceridemia during hospitalization is independently associated with 2.3 times higher mortality in COVID-19 patients. Prospective studies are needed to independently validate this retrospective analysis. National Lipid Association. Published by Elsevier Inc. 2021 2021-08-10 /pmc/articles/PMC8353976/ /pubmed/34470719 http://dx.doi.org/10.1016/j.jacl.2021.08.002 Text en © 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Dai, Wen Lund, Hayley Chen, Yiliang Zhang, Jue Osinski, Kristen Jones, Stephanie Zellner Kreuziger, Lisa Baumann López, José A. Benjamin, Ivor J. Silverstein, Roy L. Zheng, Ze Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title | Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title_full | Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title_fullStr | Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title_full_unstemmed | Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title_short | Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
title_sort | hypertriglyceridemia during hospitalization independently associates with mortality in patients with covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353976/ https://www.ncbi.nlm.nih.gov/pubmed/34470719 http://dx.doi.org/10.1016/j.jacl.2021.08.002 |
work_keys_str_mv | AT daiwen hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT lundhayley hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT chenyiliang hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT zhangjue hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT osinskikristen hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT jonesstephaniezellner hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT kreuzigerlisabaumann hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT lopezjosea hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT benjaminivorj hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT silversteinroyl hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 AT zhengze hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19 |